Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients.

López-Muñoz E, Hernández-Zarco A, García-Hernández N, Alvarado-Cabrero I, Zarco-Espinosa G, Salamanca-Gómez F, Arenas-Aranda D.

Clin Transl Oncol. 2012 Aug;14(8):586-91. doi: 10.1007/s12094-012-0845-8. Epub 2012 Jul 11.

PMID:
22855140
2.

A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females.

García N, Salamanca F, Astudillo-de la Vega H, Curiel-Quesada E, Alvarado I, Peñaloza R, Arenas D.

BMC Cancer. 2005 Aug 1;5:93.

3.

The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines.

Radetzki S, Köhne CH, von Haefen C, Gillissen B, Sturm I, Dörken B, Daniel PT.

Oncogene. 2002 Jan 10;21(2):227-38.

5.

Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma.

Sturm I, Stephan C, Gillissen B, Siebert R, Janz M, Radetzki S, Jung K, Loening S, Dörken B, Daniel PT.

Cell Death Differ. 2006 Apr;13(4):619-27.

6.

Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.

Tolhurst RS, Thomas RS, Kyle FJ, Patel H, Periyasamy M, Photiou A, Thiruchelvam PT, Lai CF, Al-Sabbagh M, Fisher RA, Barry S, Crnogorac-Jurcevic T, Martin LA, Dowsett M, Charles Coombes R, Kamalati T, Ali S, Buluwela L.

Breast Cancer Res Treat. 2011 Jul;128(2):357-68. doi: 10.1007/s10549-010-1122-6. Epub 2010 Aug 22.

PMID:
20730598
8.

miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.

Endo Y, Toyama T, Takahashi S, Yoshimoto N, Iwasa M, Asano T, Fujii Y, Yamashita H.

Endocr Relat Cancer. 2013 Feb 18;20(1):91-102. doi: 10.1530/ERC-12-0207. Print 2013 Feb.

9.

Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner.

Bretschneider N, Brand H, Miller N, Lowery AJ, Kerin MJ, Gannon F, Denger S.

Cancer Res. 2008 Jan 1;68(1):106-14. doi: 10.1158/0008-5472.CAN-07-5647.

10.

BAK, BAX, and NBK/BIK proapoptotic gene alterations in Iranian patients with ataxia telangiectasia.

Isaian A, Bogdanova NV, Houshmand M, Movahadi M, Aghamohammadi A, Rezaei N, Atarod L, Sadeghi-Shabestari M, Tonekaboni SH, Chavoshzadeh Z, Hassani SM, Mirfakhrai R, Cheraghi T, Kalantari N, Ataei M, Dork-Bousset T, Sanati MH.

J Clin Immunol. 2010 Jan;30(1):132-7. doi: 10.1007/s10875-009-9340-6. Epub 2009 Nov 7. Erratum in: J Clin Immunol. 2010 Jul;30(4):620. Agamohammadi, Asghar [corrected to Aghamohammadi, Asghar].

PMID:
19898928
11.

Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.

Yoshimoto N, Toyama T, Takahashi S, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H.

Breast Cancer Res Treat. 2011 Nov;130(1):331-9. doi: 10.1007/s10549-011-1672-2. Epub 2011 Jul 14.

PMID:
21755340
12.

Significant elevation of CLDN16 and HAPLN3 gene expression in human breast cancer.

Kuo SJ, Chien SY, Lin C, Chan SE, Tsai HT, Chen DR.

Oncol Rep. 2010 Sep;24(3):759-66.

PMID:
20664984
13.
14.

Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.

Du J, Zhou N, Liu H, Jiang F, Wang Y, Hu C, Qi H, Zhong C, Wang X, Li Z.

PLoS One. 2012;7(4):e35957. doi: 10.1371/journal.pone.0035957. Epub 2012 Apr 27.

16.

Estrogen-related receptor-γ regulates estrogen receptor-α responsiveness in uterine endometrial cancer.

Yamamoto T, Mori T, Sawada M, Kuroboshi H, Tatsumi H, Yoshioka T, Matsushima H, Iwasaku K, Kitawaki J.

Int J Gynecol Cancer. 2012 Nov;22(9):1509-16. doi: 10.1097/IGC.0b013e31826fd623.

PMID:
23051957
17.

The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis.

Hur J, Chesnes J, Coser KR, Lee RS, Geck P, Isselbacher KJ, Shioda T.

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2351-6.

18.

Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.

Han Y, Yang L, Suarez-Saiz F, San-Marina S, Cui J, Minden MD.

Mol Cancer Res. 2008 Aug;6(8):1347-55. doi: 10.1158/1541-7786.MCR-07-2179.

19.

Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.

Clin Cancer Res. 2005 Jun 15;11(12):4357-64.

20.

Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction.

de Cremoux P, Bieche I, Tran-Perennou C, Vignaud S, Boudou E, Asselain B, Lidereau R, Magdelénat H, Becette V, Sigal-Zafrani B, Spyratos F.

Endocr Relat Cancer. 2004 Sep;11(3):489-95.

Supplemental Content

Support Center